AnticoagEvaluator

AnticoagEvaluator

American College of Cardiology Foundation

Available on Google Play
4.8(67)
10,000+ installsFreeMedical

Updated Nov 21, 2024 · v5.0

CompareView on Google Play
Screenshot 1
Screenshot 2
Screenshot 3
Screenshot 4
Screenshot 5
Screenshot 6
Screenshot 7
Screenshot 8
Screenshot 9
Screenshot 10
Screenshot 11

Make informed anti thrombotic therapy decisions for AF patients.

Make well-informed decisions on anti thrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator. Use the app to: • Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed • Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention • Generate individualized risk for anti thrombotic therapy options based on individual clinical trials. • Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics. This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com

Released
December 9, 2015

10 years on Google Play

Version
5.0
Updated
Nov 21, 2024
Content Rating
Everyone
Installs
10,000+
Developer
American College of Cardiology Foundation
Website
http://www.acc.org
Email
gmuthaia@acc.org
In-app purchases
No

This app isn't currently appearing in any tracked top charts.

Rating breakdown

5
50
4
8
3
0
2
0
1
0